Daily News Podcast

Opioids do more harm than good for musculoskeletal pain


 

Opioids cannot be justified for the routine treatment for musculoskeletal pain because risks outweigh benefits. Also today, intensive treatment for type 2 diabetes pays off in the long run, diabetes patients are being pushed into high-deductible insurance plans, and obesity didn’t just happen overnight.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

New NIH consortium aims to coordinate pediatric research programs
MDedge Hematology and Oncology
Type 2 diabetes may promote Parkinson development
MDedge Hematology and Oncology
FDA database reveals many rheumatic and musculoskeletal adverse events on immunotherapies
MDedge Hematology and Oncology
Routine AAA screening for older men: more harm than good?
MDedge Hematology and Oncology
TNF inhibitor linked to one-third drop in total mortality
MDedge Hematology and Oncology
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Hematology and Oncology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Hematology and Oncology
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Hematology and Oncology
Patients going without as insulin prices skyrocket
MDedge Hematology and Oncology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Hematology and Oncology